During the 8th Microbiome Movement – Drug Development Summit, held in London at the end of January, MicrobiomePost discussed with Isabelle de Cremoux, CEO of Seventure Partners, a leading venture capital firm in Europe, about the first fecal microbiota product approved by FDA and the news that will emerge in 2023.
Isabelle de Cremoux (Seventure): ‘2023 Will Be an Excellent Year for Microbiome Research’
MicrobiomePost talked with Isabelle de Cremoux, CEO of Seventure Partners, about the news that will emerge in 2023.
Most recent
HCPs Area
Industry
- Read more about Gastroenterology, Industry, Video
